Ignite Creation Date:
2025-12-24 @ 4:37 PM
Ignite Modification Date:
2025-12-26 @ 7:15 PM
Study NCT ID:
NCT03098966
Status:
COMPLETED
Last Update Posted:
2018-01-26
First Post:
2017-03-28
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Evaluation of Trials of Labor After Previous Cesarean Section in Ain Shams University Maternity Hospital
Sponsor:
Ain Shams University
Organization:
Study Overview
Official Title:
Evaluation of Trials of Labor After Previous Cesarean Section in Ain Shams University Maternity Hospital
Status:
COMPLETED
Status Verified Date:
2017-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of the study to evaluate the practice and short term maternal and perinatal outcomes of trial of labor after cesarean section offered to women at Ain Shams University Maternity Hospital (ASUMH) during the 3-year period from January 2013 to December 2015.
Detailed Description:
This is a retrospective study that was performed at Ain Shams University Maternity Hospital.
The following data will be gathered (whenever available), tabulated and subjected to the proper statistical analysis:
History:
* Age
* Duration of marriage
* Inter-pregnancy interval
* Gestational age (by menstrual dates or US)
* Obstetric history (parity, mode of delivery, assisted vaginal delivery, previous vaginal birth after cesarean section, neonatal outcome)
* Present and past history of any medical, surgical or obstetric problems; history of infection after previous CS
General examination:
* General condition
* Vital data
Abdominal examination:
* Fundal level
* Estimated fetal weight (clinically or by US)
* Scar tenderness
Vaginal examination on admission:
* Cervical status
* Station of presenting part
* Membranes status
* Pelvic adequacy
Investigations performed:
* Complete Blood Count
* Ultrasonography
Intrapartum management:
* Progress and duration of labor according to partogram (or admission-delivery time)
* Intrapartum complications; placental abruption, uterine rupture, hysterectomy, complications during surgical intervention if any
Mode of delivery:
* Vaginal delivery (spontaneous, assisted, complications)
* Cesarean section (indication, scar dehiscence)
Postpartum Data:
* Postpartum hemorrhage
* Blood transfusion
* Neonatal outcome; fetal weight, birth trauma, Neonatal Intensive Care Unit admission, mortality
The following data will be gathered (whenever available), tabulated and subjected to the proper statistical analysis:
History:
* Age
* Duration of marriage
* Inter-pregnancy interval
* Gestational age (by menstrual dates or US)
* Obstetric history (parity, mode of delivery, assisted vaginal delivery, previous vaginal birth after cesarean section, neonatal outcome)
* Present and past history of any medical, surgical or obstetric problems; history of infection after previous CS
General examination:
* General condition
* Vital data
Abdominal examination:
* Fundal level
* Estimated fetal weight (clinically or by US)
* Scar tenderness
Vaginal examination on admission:
* Cervical status
* Station of presenting part
* Membranes status
* Pelvic adequacy
Investigations performed:
* Complete Blood Count
* Ultrasonography
Intrapartum management:
* Progress and duration of labor according to partogram (or admission-delivery time)
* Intrapartum complications; placental abruption, uterine rupture, hysterectomy, complications during surgical intervention if any
Mode of delivery:
* Vaginal delivery (spontaneous, assisted, complications)
* Cesarean section (indication, scar dehiscence)
Postpartum Data:
* Postpartum hemorrhage
* Blood transfusion
* Neonatal outcome; fetal weight, birth trauma, Neonatal Intensive Care Unit admission, mortality
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: